Group One Trading
RVPH

Group One Trading’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Group One Trading’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.9K Buy
15,000
+14,060
+1,496% +$64K ﹤0.01% 6328
2025
Q4 		$5.25K Buy
940
+810
+623% +$9.01K ﹤0.01% 7161
2025
Q3 		$958 Sell
130
-80
-38% -$680 ﹤0.01% 8064
2025
Q2 		$1.6K Sell
210
-1,430
-87% -$22.3K ﹤0.01% 7469
2025
Q1 		$31.3K Sell
1,640
-5,145
-76% -$162K ﹤0.01% 5517
2024
Q4 		$246K Buy
6,785
+4,935
+267% +$137K ﹤0.01% 3778
2024
Q3 		$53.3K Sell
1,850
-730
-28% -$16.2K ﹤0.01% 4622
2024
Q2 		$66K Sell
2,580
-80
-3% -$3.64K ﹤0.01% 4296
2024
Q1 		$201K Buy
2,660
+775
+41% +$61.4K ﹤0.01% 3558
2023
Q4 		$194K Sell
1,885
-9,590
-84% -$861K ﹤0.01% 3890
2023
Q3 		$1.12M Buy
11,475
+9,865
+613% +$920K ﹤0.01% 2150
2023
Q2 		$189K Buy
1,610
+1,570
+3,925% +$199K ﹤0.01% 3995
2023
Q1 		$3.35K Sell
40
-75
-65% -$6.55K ﹤0.01% 6457
2022
Q4 		$9.78K Buy
115
+40
+53% +$3.05K ﹤0.01% 6040
2022
Q3 		$2K Buy
+75
New +$2.07K ﹤0.01% 7195

Other funds holding RVPH

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Group One Trading's RVPH Position: Q1 2026 in Review

Group One Trading reduced its REVIVA PHARMA HLDGS INC (RVPH) stake by 0.29% in Q1 2026, selling an estimated $41 and leaving 3,109 shares worth $2.27K. The position accounts for ﹤0.01% of the portfolio, ranked #7014.

Group One Trading first reported a position in RVPH in Q3 2023 and has held it in 5 quarters since. The position peaked at $631K in Q3 2023. 35 funds tracked by Wall St. Rank hold RVPH as of Q1 2026.

  • Group One Trading held 3,109 shares of REVIVA PHARMA HLDGS INC worth $2.27K as of Q1 2026.
  • Group One Trading sold 9 REVIVA PHARMA HLDGS INC shares in Q1 2026, an estimated $41.
  • REVIVA PHARMA HLDGS INC made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7014 holding.
  • Group One Trading first reported a position in REVIVA PHARMA HLDGS INC in Q3 2023 and has held it in 5 quarters since.
  • Group One Trading's REVIVA PHARMA HLDGS INC position peaked at $631K in Q3 2023.
  • 35 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.